Clinical Trial Update: Ad Hoc Percutaneous Coronary Intervention Study in Acute Coronary Syndrome Patients [Phase 4]

View source ↗

Summary

Phase 4 trial update of ad hoc percutaneous coronary intervention in acute coronary syndrome patients has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome

Snippet

Sponsor: AstraZeneca | Conditions: Acute Coronary Syndrome | Phase 4 | Status: COMPLETED | Results posted: 2015-12-11